InsidersTradesSigma
Follow the 서울제약 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 서울제약 has published 2 insider filings. The latest transaction was reported on 30 November 2022 (Purchase). Among the most active insiders: 신봉환. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
서울제약 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the manufacturing and distribution of pharmaceutical products.